What's breaking now, across thousands of outlets.
(RTTNews) - Sandoz Group AG (SDZ.SW, SDZNY), a pharmaceutical company focused on affordable medicines, on Friday announced a collaboration with mAbxience for a proposed emicizumab biosimilar.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
[Nile Post] Uganda is struggling to reduce newborn deaths, with health officials warning that babies with life-threatening complications are dying within hours of birth because some health facilities…
Taxpayers face a Sh1 billion loss from medicines that have expired in public facilities, with senators pressing the Pharmacy and Poisons Board to strengthen oversight and prevent wastage of essential…
Complaining about work, rude strangers and poor customer service may feel natural, but researchers say chronic complaining can come with consequences.
The Nutrition Society of Nigeria (NSN) has called for increased investment in nutrition, saying improved access to nutritious food is critical to strengthening Nigeria’s workforce, productivity and…
